Revvity to Present at BofA Securities 2024 Health Care Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Revvity Inc (RVTY) PT Lowered to $120 at UBS
April 29, 2024 12:23 PM EDTUBS analyst Dan Leonard lowered the price target on Revvity Inc (NYSE: RVTY) to $120.00 (from $125.00) while maintaining a Neutral rating.
The analyst comments "Q1 results came in ahead of expectation with 3% organic revenue decline, largely driven by stronger performance in Software, ImmunoDx and newborn... More



